The pharmaceutical landscape is undergoing a structural realignment, anchored by the resurgence of oral solid dosage (OSD) platforms and the…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The biopharmaceutical industry is grappling with a profound challenge: the silent erosion of critical process knowledge, particularly "tacit knowledge," during…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The pharmaceutical industry, particularly the rapidly evolving biopharmaceutical sector, faces a silent but significant challenge: the erosion of critical "tacit…
Read More
As Cell Therapies Scale and CDMOs Cut Staff, Process Know-How Is Often Getting Lost in Tech Transfer
The biopharmaceutical industry is grappling with a critical challenge: the silent erosion of invaluable "tacit knowledge" during technology transfer processes.…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The biopharmaceutical industry, in its relentless pursuit of innovation and efficiency, faces a silent but profound challenge: the erosion of…
Read MoreYOU MAY HAVE MISSED
